Status: affected by circulating vaccine-derived poliovirus type 1 and type 2 (VDPV2)

The Philippines is affected by both circulating vaccine-derived poliovirus type 1 (cVDPV1) and circulating vaccine-derived poliovirus type 2 (cVDPV2)

Polio this week in Philippines

  • Two cVDPV2 cases were reported in the past week; one from the Southern Mindanao province and one from the National Capital Region, bringing the total number of cVDPV2 cases in 2019 to 13.
  • Additionally, two cVDPV2 positive environmental samples were reported from the National Capital Region.
  • Read our Philippines country page for more information.

WHO advice

It is important that all countries, in particular those with frequent travel and contacts with polio-affected countries and areas, strengthen surveillance for AFP cases in order to rapidly detect any new virus importation and to facilitate a rapid response. Countries, territories and areas should also maintain uniformly high routine immunization coverage at the district level to minimize the consequences of any new virus introduction.

International Health Regulations

Philippines is classified by the International Health Regulations (IHR) as a state infected with VDPV2, with potential risk of international spread. It is therefore subject to temporary recommendations as of December 2019.

Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

More on vaccine-derived polioviruses